Fragment Based Drug Design
Fragment-based drug design is a relatively new strategy for developing new drugs. It involves using small fragments of molecules, known as “hotspots,” to design more effective drugs. This strategy has become increasingly popular in recent years due to its ability to create more potent and selective drugs. The principle behind fragment-based drug design is to initially identify small, low-molecular-weight compounds, which bind to a target molecule with high affinity. This may require the use of techniques such as X-ray crystallography, NMR spectroscopy or biochemical assays. Once a fragment has been identified, it serves as a starting point for the development of a more complex molecule that has better activity and selectivity. The success of fragment-based drug design lies in the fact that it allows researchers to identify and optimize a small, specific portion of a larger molecular complex. Since it is more difficult to optimize larger molecules, this technique can greatly reduce the time and resources required to develop a new drug. Fragment-based drug design has been used in the development of many successful drugs, including cancer treatments and antibiotics. One of the key advantages of this technique is that it allows researchers to create drugs with improved selectivity, which means they target only the specific proteins involved in the disease. This helps to reduce unwanted side effects. Overall, fragment-based drug design is a promising approach to drug discovery that is likely to play an increasingly important role in the pharmaceutical industry in the future.
← Journal of Advanced Pharmaceutical Science And Technology